Literature DB >> 11682380

The recovery profile of baroreflex control of heart rate after isoflurane or sevoflurane anesthesia in humans.

G Nagasaki1, M Tanaka, T Nishikawa.   

Abstract

UNLABELLED: Volatile anesthetics attenuate baroreflex function in a concentration-dependent manner. This study was designed to determine how long full recovery of baroreflex control of heart rate takes after isoflurane or sevoflurane anesthesia in healthy volunteers. We assessed baroreflex sensitivity in 20 subjects randomized to receive either isoflurane or sevoflurane (n = 10 each). After an 8- to 10-h fast and no premedication, mea- surements of R-R intervals obtained from the electrocardiogram (lead II) and systolic blood pressure (SBP) measured through a radial artery catheter were made at conscious baseline and 20, 60, and 120 min after the induction during end-tidal isoflurane 1.3% or sevoflurane 2.0% in air and oxygen, and 20, 60, 120, and 180 min after the emergence from general anesthesia. Baroreflex responses were triggered by bolus IV injection of phenylephrine and nitroprusside to increase and decrease SBP by 15-30 mm Hg, respectively. The linear portions of the baroreflex curves relating R-R intervals and SBP were determined to obtain baroreflex sensitivity. During anesthesia, baroreflex sensitivities of both the pressor and depressor tests were decreased by 50%-60% compared with conscious baseline values in both groups (P <0.05). Pressor test sensitivities returned to the baseline values at 120 min, whereas depressor test sensitivities returned to the baseline values at 60 min, after general anesthesia in both groups. There were no significant differences in baroreflex sensitivities between groups at any interval. Our results indicate that the recovery characteristics of baroreflex sensitivity are similar after isoflurane and sevoflurane anesthesia and that the depressor test sensitivity is restored more rapidly than the pressor test sensitivity after both anesthetic techniques. IMPLICATIONS: Arterial baroreflex function is an important neural control system for maintaining cardiovascular stability. The authors found that 2 h was required for full recovery of baroreflex function and that recovery characteristics were similar after isoflurane and sevoflurane anesthesia in healthy volunteers not undergoing surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682380     DOI: 10.1097/00000539-200111000-00012

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

Review 1.  [Anesthesia management in implantation of baroreceptor stimulators].

Authors:  T Werner; L Lebar; S Wittmann; A Keyser; M Fischer; J Schmidli; B M Graf; Y A Zausig
Journal:  Anaesthesist       Date:  2015-09       Impact factor: 1.041

2.  AT2 and MAS (but not AT1) angiotensinergic receptors in the medial amygdaloid nucleus modulate the baroreflex activity in rats.

Authors:  Willian Costa-Ferreira; Lucas Gomes-de-Souza; Carlos C Crestani
Journal:  Pflugers Arch       Date:  2019-08-08       Impact factor: 3.657

Review 3.  Induction of anaesthesia: a guide to drug choice.

Authors:  Nathalie Nathan; Isabelle Odin
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Dynamic assessment of baroreflex control of heart rate during induction of propofol anesthesia using a point process method.

Authors:  Zhe Chen; Patrick L Purdon; Grace Harrell; Eric T Pierce; John Walsh; Emery N Brown; Riccardo Barbieri
Journal:  Ann Biomed Eng       Date:  2010-10-13       Impact factor: 3.934

5.  Comparison of equi-minimum alveolar concentration of sevoflurane and isoflurane on bispectral index values during both wash in and wash out phases: A prospective randomised study.

Authors:  Madhu Gupta; Iti Shri; Prashant Sakia; Deepika Govil
Journal:  Indian J Anaesth       Date:  2015-02

6.  The rat: a laboratory model for studies of the diving response.

Authors:  W Michael Panneton; Qi Gan; Rajko Juric
Journal:  J Appl Physiol (1985)       Date:  2010-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.